<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font25 { font-size : 25; } .font28 { font-size : 28; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">vaccine </span>
   <span class="font28">coronavirus </span>
   <span class="font25">;():–. </span>
   <span class="font22">COVID- </span>
   <span class="font22">protein </span>
   <span class="font21">vaccines </span>
   <span class="font20">CoV </span>
   <span class="font20">MERS-CoV </span>
   <span class="font20">drugs </span>
   <span class="font20">respiratory </span>
   <span class="font20">virus </span>
   <span class="font19">{border-style </span>
   <span class="font19">SARS-CoV </span>
   <span class="font19">novel </span>
   <span class="font18">neutralizing </span>
   <span class="font18">px;} </span>
   <span class="font18">used </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">antibodies </span>
   <span class="font18">therapeutic </span>
   <span class="font17">animal </span>
   <span class="font17">human </span>
   <span class="font16">SARS-CoV- </span>
   <span class="font16">clinical </span>
   <span class="font16">developing </span>
   <span class="font16">effective </span>
   <span class="font16">antiviral </span>
   <span class="font16">cell </span>
   <span class="font15">SARS </span>
   <span class="font15">Virol. </span>
   <span class="font15">acute </span>
   <span class="font15">immune </span>
   <span class="font15">spike </span>
   <span class="font15">development </span>
   <span class="font15">emerging </span>
   <span class="font15">infection </span>
   <span class="font15">model </span>
   <span class="font15">models </span>
   <span class="font15">potential </span>
   <span class="font15">severe </span>
   <span class="font15">therapeutics </span>
   <span class="font14">COVID-. </span>
   <span class="font14">MERS </span>
   <span class="font14">efficacy </span>
   <span class="font14">epitopes </span>
   <span class="font14">mAbs </span>
   <span class="font14">syndrome </span>
   <span class="font14">viral </span>
   <span class="font14">develop </span>
   <span class="font14">inhibitors </span>
   <span class="font14">target </span>
   <span class="font13">Research </span>
   <span class="font13">SARS- </span>
   <span class="font13">antibody </span>
   <span class="font13">available </span>
   <span class="font13">cells </span>
   <span class="font13">control </span>
   <span class="font13">doi:./... </span>
   <span class="font13">evaluated </span>
   <span class="font13">host </span>
   <span class="font13">major </span>
   <span class="font13">options </span>
   <span class="font13">patients </span>
   <span class="font13">proteins </span>
   <span class="font13">px; </span>
   <span class="font13">receptor </span>
   <span class="font13">responses </span>
   <span class="font13">{font-family </span>
   <span class="font13">East </span>
   <span class="font13">Infect. </span>
   <span class="font13">Nat </span>
   <span class="font13">Res. </span>
   <span class="font13">Veterinary </span>
   <span class="font13">drug </span>
   <span class="font13">efforts </span>
   <span class="font13">font-size </span>
   <span class="font13">immunity </span>
   <span class="font13">immunization </span>
   <span class="font13">infection. </span>
   <span class="font13">mouse </span>
   <span class="font13">required </span>
   <span class="font13">safety </span>
   <span class="font13">treatment </span>
   <span class="font12">;():. </span>
   <span class="font12">;:. </span>
   <span class="font12">;:–. </span>
   <span class="font12">CoVs </span>
   <span class="font12">Hence, </span>
   <span class="font12">MERS-CoV. </span>
   <span class="font12">Middle </span>
   <span class="font12">RBD </span>
   <span class="font12">RNA </span>
   <span class="font12">Rev </span>
   <span class="font12">advances </span>
   <span class="font12">animals </span>
   <span class="font12">common </span>
   <span class="font12">designing </span>
   <span class="font12">double; </span>
   <span class="font12">entry </span>
   <span class="font12">evaluation </span>
   <span class="font12">glycoprotein </span>
   <span class="font12">including </span>
   <span class="font12">protection </span>
   <span class="font12">remdesivir </span>
   <span class="font12">responses. </span>
   <span class="font12">shown </span>
   <span class="font12">specific </span>
   <span class="font12">strategies </span>
   <span class="font12">study </span>
   <span class="font12">targeting </span>
   <span class="font12">use </span>
   <span class="font12">vaccines, </span>
   <span class="font12">virus, </span>
   <span class="font12">vitro </span>
   <span class="font12">COVID-, </span>
   <span class="font12">China </span>
   <span class="font12">Microbes </span>
   <span class="font12">Microbiol. </span>
   <span class="font12">T-cell </span>
   <span class="font12">agents </span>
   <span class="font12">article </span>
   <span class="font12">based </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">candidates </span>
   <span class="font12">chloroquine </span>
   <span class="font12">combination </span>
   <span class="font12">controlling </span>
   <span class="font12">different </span>
   <span class="font12">doi:./s---. </span>
   <span class="font12">efficacy. </span>
   <span class="font12">evaluating </span>
   <span class="font12">expressing </span>
   <span class="font12">genome </span>
   <span class="font12">highly </span>
   <span class="font12">infections </span>
   <span class="font12">infections. </span>
   <span class="font12">inhibitors, </span>
   <span class="font12">lopinavir/ritonavir </span>
   <span class="font12">measures </span>
   <span class="font12">mice </span>
   <span class="font12">mice. </span>
   <span class="font12">new </span>
   <span class="font12">ongoing </span>
   <span class="font12">outbreak </span>
   <span class="font12">pneumonia </span>
   <span class="font12">protease </span>
   <span class="font12">solid; </span>
   <span class="font12">systemic </span>
   <span class="font12">trials </span>
   <span class="font12">using </span>
   <span class="font12">virus. </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">.collab: </span>
   <span class="font11">CEPI </span>
   <span class="font11">CoVs. </span>
   <span class="font11">Dis. </span>
   <span class="font11">Division </span>
   <span class="font11">DuL, </span>
   <span class="font11">Emerging </span>
   <span class="font11">Infect </span>
   <span class="font11">Med </span>
   <span class="font11">RBD-specific </span>
   <span class="font11">SARS-CoV, </span>
   <span class="font11">Thus, </span>
   <span class="font11">Virus </span>
   <span class="font11">[accessed </span>
   <span class="font11">agent </span>
   <span class="font11">binding </span>
   <span class="font11">bold </span>
   <span class="font11">candidate </span>
   <span class="font11">coronaviruses. </span>
   <span class="font11">counter </span>
   <span class="font11">courier; </span>
   <span class="font11">development. </span>
   <span class="font11">directed </span>
   <span class="font11">disease </span>
   <span class="font11">doi:./JVI.-. </span>
   <span class="font11">doi:./jmv.. </span>
   <span class="font11">drugs, </span>
   <span class="font11">em; </span>
   <span class="font11">full-length </span>
   <span class="font11">functions </span>
   <span class="font11">identifying </span>
   <span class="font11">induces </span>
   <span class="font11">infected </span>
   <span class="font11">infectious </span>
   <span class="font11">inhibitors. </span>
   <span class="font11">lack </span>
   <span class="font11">molecular </span>
   <span class="font11">option </span>
   <span class="font11">platform </span>
   <span class="font11">possible </span>
   <span class="font11">preventive </span>
   <span class="font11">protective </span>
   <span class="font11">protein. </span>
   <span class="font11">pt;} </span>
   <span class="font11">recent </span>
   <span class="font11">replication. </span>
   <span class="font11">rhesus </span>
   <span class="font11">similarity </span>
   <span class="font11">strain </span>
   <span class="font11">subunit </span>
   <span class="font11">suitable </span>
   <span class="font11">treating </span>
  </p>
 </body>
</html>
